Koyfin Home > Directory > Health Care > Abeona Therapeutics > Cash Flow from Operations

Abeona Therapeutics Cash Flow from Operations Chart (ABEO)

Abeona Therapeutics annual/quarterly Cash Flow from Operations from 2010 to 2020. Cash flow from operating activities (CFO) is an accounting item that indicates the amount of money a company brings in from ongoing, regular business activities, such as manufacturing and selling goods or providing a service. Cash flow from operating activities does not include long-term capital or investment costs.
  • Abeona Therapeutics Cash Flow from Operations for the quarter ending June 06, 2020 was $-9m a -92.65% increase of 9m year over year
  • Abeona Therapeutics Cash Flow from Operations for the last 12 months ending June 06, 2020 was $-55m a -18.72% increase of 10m year over year
  • Abeona Therapeutics Annual Cash Flow from Operations for 2019 was $-63m a 37.74% decrease of -24m from 2018
  • Abeona Therapeutics Annual Cash Flow from Operations for 2018 was $-39m a 42.08% decrease of -16m from 2017
  • Abeona Therapeutics Annual Cash Flow from Operations for 2017 was $-23m a 42.56% decrease of -10m from 2016
Other Cash Flow Metrics:
  • Abeona Therapeutics Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $-5m a 46.02% decrease of -2m year over year
  • Abeona Therapeutics Total Revenue for the quarter ending September 09, 2018 was $2m a 87.42% increase of 1m year over year
View Chart On Koyfin

Quarterly ABEO Cash Flow from Operations Data

06/2020$-9m
03/2020$-13m
12/2019$-14m
09/2019$-18m
06/2019$-15m
03/2019$-15m
12/2018$-17m
09/2018$-9m
06/2018$-9m
03/2018$-4m

Annual ABEO Cash Flow from Operations Data

2019$-63m
2018$-39m
2017$-23m
2016$-13m
2015$-10m
2014$-2m
2013$0m
2012$-4m
2011$-8m
2010$-7m